Financial Data and Key Metrics Changes - Earnings per share increased by 30% year-over-year, with a return on tangible equity of 20% [3] - Net interest income rose to $600 million, up $22 million from the previous quarter, driven by a tax equivalent margin of 4.06% [6][8] - Charge-offs were reported at 27 basis points for the quarter, with year-to-date charge-offs at 12 basis points [4][8] Business Line Data and Key Metrics Changes - Loan production reached nearly $3.4 billion, with a 67% increase in loan production in Texas and Colorado since the first quarter [3] - Commercial and industrial lending saw a 9% linked quarter annualized growth, while residential growth was about 6% [17][18] - Non-interest income increased to $99 million from $87 million, with capital markets contributing significantly [32] Market Data and Key Metrics Changes - The company identified approximately $90 billion in overlapping deposits in the Southeast, Texas, and Colorado, indicating potential growth opportunities [5] - The loan pipeline in Texas grew from $800 million to $1.2 billion, with Florida and Atlanta also showing significant pipeline growth [18] Company Strategy and Development Direction - The company is focused on organic growth and recruiting efforts in response to market disruptions, particularly in Texas and Colorado [5][19] - Management is contemplating adjustments to incentive structures to encourage recruiting and hiring in 2026 [42] Management's Comments on Operating Environment and Future Outlook - The management expressed confidence in achieving mid-single-digit loan growth for the remainder of 2025, with potential for higher growth in 2026 [17] - The company is well-positioned to capitalize on market disruptions and is focused on building out its infrastructure [4][5] Other Important Information - The company redeemed $405 million in subordinated debt late in the quarter, which is expected to positively impact net interest margin [6][7] - The tangible book value per share increased to $54.48, reflecting strong capital levels despite the dilutive impact of the Independent Financial merger [8] Q&A Session Summary Question: Can you walk us through the margin question? - Management discussed the impact of higher accretion and the dynamics of loan and deposit pricing in light of potential rate cuts [10][11] Question: What is the outlook for loan growth? - Management guided for mid-single-digit growth for the remainder of 2025, with a focus on commercial and industrial lending [16][17] Question: How do you feel about the credit portfolio? - Management confirmed the large charge-off was related to a specific credit and stated that the rest of the portfolio remains stable [24][25] Question: What is the optimal CET1 ratio? - Management indicated a healthy CET1 ratio of 11.5% and expressed no specific target but a preference for the 11% to 12% range [26] Question: Can you provide insights on non-interest income? - Management noted a significant increase in non-interest income, particularly from capital markets, and provided a cautious outlook for future quarters [31][32] Question: What are the expectations for deposit beta? - Management expects a deposit beta of around 27% to 30% in the next easing cycle, indicating a lag in response to rate cuts [39][66] Question: What is the guidance for NIE in the fourth quarter? - Management maintained guidance for NIE in the range of $345 million to $350 million for Q4 [67]

Financial Data and Key Metrics Changes - Sales for Q3 2025 totaled $468 million, reflecting an 8% growth on a reported basis and 7% growth organically [13][9] - Adjusted operating income increased by 14% year-over-year, with adjusted EPS growing by 25% to $1.79 [15][9] - For the full year 2025, the company expects sales growth between 7% and 8%, with adjusted operating income growth between 12% and 14% [20][10] Business Line Data and Key Metrics Changes - Cardio and vascular sales increased by 15% in Q3 2025, driven by new product ramps and strong demand in neurovascular [15] - Cardiac rhythm management solutions sales increased by 18% year-over-year, but growth is expected to decelerate in Q4 2025 due to anticipated declines in new products [16][10] - Neuromodulation sales increased by 2% in Q3 2025, with expectations for low single-digit growth for the full year [17] Market Data and Key Metrics Changes - The company anticipates a 3% to 4% headwind to total sales in 2026 due to slower market adoption of three new products [11][25] - The portable medical exit is expected to contribute a 2% headwind to total sales in 2026 [11][25] - The overall market in which the company competes is growing at a steady mid-single digit rate [29] Company Strategy and Development Direction - The company remains confident in its long-term growth strategy, focusing on early design wins in high-growth markets [12][29] - A strong product development pipeline is expected to drive above-market growth in 2027 [28][29] - The company plans to continue its acquisition strategy while maintaining a leverage ratio within the targeted range of 2.5 to 3.5x [29] Management's Comments on Operating Environment and Future Outlook - Management acknowledged recent customer forecast changes impacting the financial outlook but expressed confidence in the long-term strategy [5][10] - The company expects a recovery to market growth in the second half of 2026 as new product headwinds moderate [11][12] - Management highlighted the unusual nature of simultaneous forecast changes from multiple customers as a significant factor affecting the outlook [59] Other Important Information - The adjusted effective tax rate for Q3 2025 was 16.3%, down from 17.2% in the prior year, with expectations for the full year to be within the range of 17%-18% [18] - The company generated $66 million of cash flow from operations in Q3 2025, with free cash flow remaining flat at $46 million [19] Q&A Session Summary Question: Can you elaborate on the organic growth of the rest of the portfolio? - Management indicated that without new product introductions, the rest of the portfolio is expected to grow at market rates, which is lower than the typical 6%-8% growth [32][33] Question: What are the expected headwinds in the cardio and vascular items? - The headwinds are related to two electrophysiology products with slower market adoption than anticipated, not due to loss of market share [34][36] Question: How confident is the company in returning to market growth by Q4 2026? - Management expressed confidence due to steady backlog and customer forecasts, despite the unusual simultaneous changes in multiple products [38][39] Question: What is the nature of the changes in the electrophysiology products? - The changes are due to customers adjusting their forecasts based on lower-than-expected market adoption rates [42][46] Question: Is the decline in neuromodulation similar to electrophysiology? - Yes, the decline is attributed to slower market adoption from emerging customers, although the overall book of business is still growing [52][57] Question: How does the company plan to manage costs in 2026? - The company will focus on operational efficiencies and disciplined cost management to navigate the expected headwinds [85][86]

Financial Data and Key Metrics Changes - The company reported GAAP net income for the quarter of $1.2 billion and distributable earnings of $1.9 billion, or $1.52 per common share, marking a 48% year-over-year increase [5][34] - Distributable earnings increased nearly 50% year on year, driven by a 26% growth in fee-related earnings and a more than doubling of net realizations [8][34] - Total assets under management (AUM) rose 12% year over year to $1.24 trillion, with fee-earning AUM growing 10% to $906 billion [32] Business Line Data and Key Metrics Changes - In corporate and real estate credit, AUM crossed the $500 billion milestone, up 18% year over year [19] - The infrastructure and asset-based credit business grew 29% year over year to $107 billion, one of the fastest-growing areas [20] - The private wealth channel's AUM grew 15% year over year to nearly $290 billion, with over $11 billion raised in the third quarter, more than doubling year over year [24][25] Market Data and Key Metrics Changes - The company executed three successful IPOs in the last three months, with a robust pipeline for the next 12 months [10][35] - The commercial real estate market is showing signs of recovery, with values bottoming in December 2023 and transaction activity increasing by 25% year over year in U.S. logistics [30] - The demand for data center space continues to grow, with a doubling in the leasing pipeline globally in Q3 compared to Q2 [63] Company Strategy and Development Direction - The company aims to capture generational shifts in the global economy and markets, focusing on massive capital solutions across various sectors, including AI, energy infrastructure, and life sciences [17] - The firm is positioned to lead the evolution of private credit markets, expanding from non-investment grade corporate credit to include commercial finance and infrastructure [20] - The company plans to broaden distribution in major markets and deepen its presence in key sub-channels, including the RIA channel [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the firm's growth prospects, citing strong structural tailwinds in the alternative sector and increasing allocations to alternatives by institutional investors [8][9] - The company anticipates a resurgence in capital markets activity, which should lead to greater realizations and support fundraising and deployment [10] - Despite recent credit defaults in the market, management emphasized that these events are not reflective of the private credit market and that defaults remain minimal [11][42] Other Important Information - The company celebrated its 40th anniversary, highlighting its growth from a startup to the largest alternative asset manager in the world [14] - The firm has achieved significant organic growth, distinguishing itself from competitors who often rely on acquisitions [14][15] Q&A Session Summary Question: Changes in credit quality across the portfolio - Management clarified that recent credit issues are not related to private credit but rather to bank-led credits, emphasizing minimal realized losses and strong credit quality [41][42] Question: Plans for the defined contribution business - Management discussed the importance of building capabilities in this area and indicated plans to work with existing partners while awaiting regulatory developments [44][45] Question: Brand strategy and marketing evolution - Management noted targeted marketing efforts, including a recent launch in Japan, and emphasized the importance of expanding the brand's footprint in private wealth [47][49] Question: Interplay between margin outlook and realizations - Management indicated that operating leverage will continue to support healthy fee-related earnings margins, with a favorable outlook for realizations as capital markets strengthen [52][53] Question: Feedback on BCRED's dividend cut - Management reported healthy gross sales and expected strong flows in BCRED, emphasizing the importance of delivering relative premium returns [68][78]

Hexcel (NYSE:HXL) Q3 2025 Earnings Call October 23, 2025 09:00 AM ET Company ParticipantsSheila Kahyaoglu - Managing DirectorTom Gentile - CEO, Chairman, and PresidentPete Skibitski - Director of Aerospace and Defense Equity ResearchRichard Safran - Managing Director of Aerospace and DefensePatrick Winterlich - EVP and CFOKurt Goddard - VP of Investor RelationsScott Deuschle - Director of Aerospace and Defense Equity ResearchMyles Walton - Managing DirectorGavin Parsons - Director of Aerospace and Defense E ...

Financial Data and Key Metrics Changes - The combined adjusted EBITDA for the third quarter was $245 million, compared to $237 million in Q3 2024 and $250 million in the previous quarter [10] - Total net sales for the quarter were $1.6 billion, up from $1.4 billion year-over-year, with gross margins improving to 24.7% from 22.1% [10][16] - Net income for the quarter was $19.4 million, or $0.12 per diluted share, compared to $16.9 million, or $0.11 per diluted share in Q3 2024 [16] Business Line Data and Key Metrics Changes - In the feed segment, EBITDA improved to $174 million from $132 million a year ago, with total sales reaching $1 billion compared to $928 million [10] - The food segment saw total sales of $381 million, up from $357 million in Q3 2024, with gross margins increasing to 27.5% from 23.9% [11] - The fuel segment, specifically Diamond Green Diesel (DGD), reported an EBITDA of -$3 million, down from +$39 million in Q3 2024, impacted by operational challenges and market dynamics [12][14] Market Data and Key Metrics Changes - Global rendering volumes and margins in the feed segment were up both sequentially and year-over-year, driven by strong demand for fats and proteins [7] - In the U.S., demand for domestic fats was robust, supported by strong agricultural and energy policies, boosting revenue and margins [8] - Export protein demand showed signs of recovery, with slightly firmer pricing trends emerging, although tariff implications affected value-added poultry protein products [8] Company Strategy and Development Direction - The company is focused on its core ingredients business, expecting EBITDA for 2025 to be in the range of $875 to $900 million, excluding DGD [17] - The management believes that the integrated model of Darling Ingredients provides a competitive advantage that is unmatched in the industry [5] - The company anticipates a shift in the renewables market that will enhance DGD's earnings potential, contingent on favorable public policy [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the core ingredients business despite short-term challenges in the renewables market due to policy uncertainties [5][9] - The management highlighted that the Renewable Volume Obligation (RVO) is expected to support American agriculture and energy leadership, which could be a catalyst for future growth [17] - There is optimism regarding the recovery of margins in the fourth quarter, although caution was advised due to ongoing regulatory uncertainties [64] Other Important Information - Total debt net of cash was $4.01 billion, a slight increase from $3.97 billion at year-end 2024, with capital expenditures totaling $90 million in Q3 [15] - The company recorded an income tax benefit of $1.2 million for the quarter, yielding an effective tax rate of -6.3% [16] - The company expects to generate around $300 million in production tax credits (PTCs) in 2025, with significant sales anticipated in the fourth quarter [13][14] Q&A Session Summary Question: Timeline for clarity on regulatory items like RVO - Management expects clarity on RVO and related regulatory items by December, despite the government shutdown [22] Question: Outlook for feed segment in Q4 - Management indicated that while waste fat prices have dipped, they expect the food segment to be stronger in Q4, with overall performance close to the previous quarter [24] Question: Benefits of REMS policy protectionism - Management noted that the treatment of foreign feedstocks is still unclear, and the overall supply and demand for fats and oils will influence the feed business [28][29] Question: Drivers of DGD margins - Management clarified that the DGD results were impacted by LCM and operational challenges, and they are optimistic about future margin improvements [34][39] Question: Plans for debt repayment and leverage ratios - Management confirmed they are committed to paying down debt and expect their debt coverage ratio to be around three by year-end [51][52] Question: RIN pricing scenarios and industry compliance - Management indicated that RIN prices may not see a significant lift until clarity on enforcement dates is provided, which is expected by the end of the year [76]

Financial Data and Key Metrics Changes - The company reported third-quarter GAAP earnings of $0.76 per share, an increase from $0.73 in the same quarter last year [4] - Core earnings for the quarter were $0.83 per share, compared to $0.76 in Q3 2024, and year-to-date core earnings reached $2.02 per share, up 15% from $1.76 in 2024 [4][18] - The company invested $4 billion in capital for regulated utilities in the first nine months of 2025, a 30% increase compared to the previous year [4][22] - The updated guidance for 2025 is raised to a midpoint of $2.53 per share, with a range of $2.50-$2.56 [5][16] Business Line Data and Key Metrics Changes - Distribution business earnings improved by 20% year-to-date due to a $225 million annual rate adjustment in Pennsylvania and higher customer demand [19] - Integrated segment earnings increased by $0.05 per share, or 7%, driven by formula rate investments in transmission systems [19] - Standalone transmission business earnings rose approximately 7%, supported by a strong capital investment program [19] Market Data and Key Metrics Changes - The contracted customer demand from data centers increased by over 30% since the last earnings call, with expectations for FirstEnergy's system peak load to rise by 15 GW by 2035 [7] - The overall sales were 1% higher than last year, remaining flat on a weather-adjusted basis [21] Company Strategy and Development Direction - The company is increasing its 2025 capital investment program by 10% to $5.5 billion, focusing on system reliability and resiliency [5][12] - A long-term integrated resource plan in West Virginia aims to add 70 MW of utility-scale solar and 1.2 GW of natural gas generation by 2031 [9][10] - The company is committed to maintaining affordability for customers, with average bills 19% below in-state peers [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a core earnings compound annual growth rate of 6%-8% through 2029, supported by increased capital investments [16][18] - The company is actively engaging with regulators to address rising consumer energy costs and advocating for changes in capacity auctions [62][80] Other Important Information - The company successfully completed its 2025 financing plan with nearly $6 billion in debt financing, demonstrating a strong credit profile [24] - The company expects an order in the Ohio base rate case in November, followed by a multi-year rate plan filing [25] Q&A Session Summary Question: Discussion on West Virginia generation and capital recovery - Management explained that for build-own-transfer scenarios, capital recovery would occur during construction, with significant earnings coming once the asset is operational [32] Question: Thoughts on increased CapEx opportunities - Management indicated that increased CapEx would support the 6%-8% earnings per share growth outlook, with confidence in achieving the upper end of that range [38][83] Question: Data center pipeline activity - Management confirmed that there is currently about $1 billion of CapEx associated with transmission interconnection requests from large load customers [41] Question: Affordability pressures in New Jersey - Management acknowledged that generation costs are driving bill increases and emphasized efforts to mitigate these impacts for customers [62] Question: Transmission upside and open window outcomes - Management stated that the 30% increase in transmission CapEx is based on incremental work rather than inflation, with a modest amount from pending PJM open window projects included in the plan [66][68]

Brandywine Realty Trust (NYSE:BDN) Q3 2025 Earnings Call October 23, 2025 09:00 AM ET Company ParticipantsManus Ebbecke - Senior AssociateTom Wirth - EVP and CFOGeorge Johnstone - EVP, OperationsJerry Sweeney - President and CEOConference Call ParticipantsUpal Rana - Senior Equity Research Analyst US REITsDylan Burzinski - Senior Analyst, Equity ResearchNone - AnalystOperatorThank you for standing by and welcome to the Brandywine Realty Trust Third Quarter 2025 earnings call. At this time, all participants ...

Live Oak Bancshares (NYSE:LOB) Q3 2025 Earnings Call October 23, 2025 09:00 AM ET Company ParticipantsMichael Cairns - CCOWalter Phifer - CFOWilliam Losch III - President and COOGreg Seward - General Counsel and Chief Risk OfficerChip Mahan - Chairman and CEOConference Call ParticipantsDavid Rochester - Managing Director and Senior Banks AnalystBill Young - AnalystTim Switzer - VP and Equity Research AnalystDavid Feaster - AnalystOperatorGood morning, ladies and gentlemen, and welcome to the Live Oak Bancsh ...

Hexcel (NYSE:HXL) Q3 2025 Earnings Call October 23, 2025 09:00 AM ET Company ParticipantsSheila Kahyaoglu - Managing DirectorTom Gentile - CEO, Chairman, and PresidentPete Skibitski - Director of Aerospace and Defense Equity ResearchRichard Safran - Managing Director of Aerospace and DefensePatrick Winterlich - EVP and CFOKurt Goddard - VP of Investor RelationsScott Deuschle - Director of Aerospace and Defense Equity ResearchMyles Walton - Managing DirectorGavin Parsons - Director of Aerospace and Defense E ...

Live Oak Bancshares (NYSE:LOB) Q3 2025 Earnings Call October 23, 2025 09:00 AM ET Company ParticipantsMichael Cairns - CCOWalter Phifer - CFOWilliam Losch III - President and COOGreg Seward - General Counsel and Chief Risk OfficerChip Mahan - Chairman and CEOConference Call ParticipantsDavid Rochester - Managing Director and Senior Banks AnalystBill Young - AnalystTim Switzer - VP and Equity Research AnalystDavid Feaster - AnalystOperatorGood morning, ladies and gentlemen, and welcome to the Live Oak Bancsh ...